Chemoinformaics analysis of Naringin-7-O-Alpha-L-Rhamno-Glucoside
| Molecular Weight | 580.539 | nRot | 6 |
| Heavy Atom Molecular Weight | 548.283 | nRig | 30 |
| Exact Molecular Weight | 580.179 | nRing | 5 |
| Solubility: LogS | -3.43 | nHRing | 3 |
| Solubility: LogP | -0.493 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 73 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 2 |
| nHetero | 14 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 14 | No. of Arom Bond | 12 |
| nHA | 14 | APOL | 77.6554 |
| nHD | 8 | BPOL | 41.6506 |
| QED | 0.202 |
| Synth | 4.738 |
| Natural Product Likeliness | 2.246 |
| NR-PPAR-gamma | 0.94 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.974 |
| HIA | 0.927 |
| CACO-2 | -6.501 |
| MDCK | 0.0000937 |
| BBB | 0.347 |
| PPB | 0.787384 |
| VDSS | 0.372 |
| FU | 0.219088 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.025 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.124 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.682 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.196 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.058 |
| CL | 1.489 |
| T12 | 0.202 |
| hERG | 0.015 |
| Ames | 0.348 |
| ROA | 0.245 |
| SkinSen | 0.031 |
| Carcinogencity | 0.795 |
| EI | 0.007 |
| Respiratory | 0.033 |
| NR-Aromatase | 0.516 |
| Antiviral | Yes |
| Prediction | 0.863477 |